{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:19:24Z","timestamp":1787775564550,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The axillary reverse mapping (ARM) technique identifies and preserves arm nodes during sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND). Here, we aimed to investigate the prevalence of lymphedema following ARM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This is a clinical trial that was performed in 2019-2020 in Isfahan on patients with breast cancer in the early stages. Demographic and initial information of all cases including age and body mass index (BMI) was collected. Patients were then underwent SLNB \u00b1 ALND associated with ARM and were followed up for lymphedema every 6 months to a year. The occurrence of lymphedema was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      By evaluating data of 102 patients, we found that 10 patients (9.8%) had lymphedema and patients with lymphedema had significantly higher age (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004), higher BMI (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), larger tumor size (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.018), and longer surgery duration (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The frequency of menopausal women was higher in patients with lymphedema compared to other cases (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The prevalence of lymphedema was high among patients undergoing ARM that was associated with factors including higher age, higher BMI, prolonged surgery duration, larger tumor size, and menopause. We believe that further comparative studies should be conducted on this issue.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_281_21","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:54:15Z","timestamp":1651200855000},"page":"36","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Relative Abundance of Lymphedema after Reverse Axillary Mapping in Patients with Breast Cancer"],"prefix":"10.4103","volume":"11","author":[{"given":"Reza","family":"Eshraghi Samani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Rafiee Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Safaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20240830","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: A review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"R2-36-20240830","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.lpm.2019.09.022","article-title":"Breast cancer epidemiology","volume":"48","author":"Sancho-Garnier","year":"2019","journal-title":"Presse Med"},{"key":"R3-36-20240830","first-page":"243","article-title":"Epidemiology and histopathology of breast cancer in Iran versus other Middle Eastern countries","volume":"9","author":"Nafissi","year":"2018","journal-title":"Middle East J Cancer"},{"key":"R4-36-20240830","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.canep.2015.04.016","article-title":"Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report","volume":"39","author":"Jazayeri","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"R5-36-20240830","first-page":"430","article-title":"Epidemiology and trends in breast cancer mortality in Iran","volume":"44","author":"Enayatrad","year":"2015","journal-title":"Iran J Public Health"},{"key":"R6-36-20240830","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijsu.2020.01.152","article-title":"Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients \u2013 Randomised controlled trial","volume":"75","author":"Abdelhamid","year":"2020","journal-title":"Int J Surg"},{"key":"R7-36-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12282-018-0886-0","article-title":"Axillary reverse mapping (ARM): Where to go","volume":"26","author":"Shao","year":"2019","journal-title":"Breast Cancer"},{"key":"R8-36-20240830","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12957-020-01886-9","article-title":"Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema","volume":"18","author":"Liu","year":"2020","journal-title":"World J Surg Oncol"},{"key":"R9-36-20240830","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMcp1803290","article-title":"Lymphedema after breast cancer treatment","volume":"379","author":"Rockson","year":"2018","journal-title":"N Engl J Med"},{"key":"R10-36-20240830","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1245\/s10434-017-5960-x","article-title":"Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: Results from a large cohort study","volume":"24","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R11-36-20240830","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s00520-018-4186-1","article-title":"Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB","volume":"26","author":"Belmonte","year":"2018","journal-title":"Support Care Cancer"},{"key":"R12-36-20240830","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.25513","article-title":"Axillary reverse mapping and lymphaticovenous bypass: Lymphedema prevention through enhanced lymphatic visualization and restoration of flow","volume":"120","author":"Schwarz","year":"2019","journal-title":"J Surg Oncol"},{"key":"R13-36-20240830","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jso.24859","article-title":"Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes","volume":"117","author":"Foster","year":"2018","journal-title":"J Surg Oncol"},{"key":"R14-36-20240830","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4048\/jbc.2012.15.1.91","article-title":"The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer","volume":"15","author":"Han","year":"2012","journal-title":"J Breast Cancer"},{"key":"R15-36-20240830","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.amjsurg.2009.06.008","article-title":"Scientific impact award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy","volume":"198","author":"Boneti","year":"2009","journal-title":"Am J Surg"},{"key":"R16-36-20240830","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-014-2856-3","article-title":"Risk of lymphedema after mastectomy: Potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients","volume":"144","author":"Miller","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R17-36-20240830","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/SLA.0000000000001778","article-title":"Does axillary reverse mapping prevent lymphedema after lymphadenectomy?","volume":"265","author":"Tummel","year":"2017","journal-title":"Ann Surg"},{"key":"R18-36-20240830","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clbc.2015.01.010","article-title":"A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients","volume":"15","author":"Yue","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"R19-36-20240830","first-page":"421","article-title":"Axillary reverse mapping (ARM): Initial results of phase II trial in preventing lymphedema after lymphadenectomy","volume":"64","author":"Boneti","year":"2012","journal-title":"Minerva Ginecol"},{"key":"R20-36-20240830","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.surg.2014.05.011","article-title":"Axillary reverse mapping: Five-year experience","volume":"156","author":"Ochoa","year":"2014","journal-title":"Surgery"},{"key":"R21-36-20240830","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejso.2014.03.023","article-title":"The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients","volume":"40","author":"Ikeda","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"R22-36-20240830","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ejso.2013.09.022","article-title":"Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema","volume":"39","author":"Gennaro","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"R23-36-20240830","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13037-019-0217-1","article-title":"Prevention of lymphedema via axillary reverse mapping for arm lymph-node preservation following breast cancer surgery: A randomized controlled trial","volume":"13","author":"Faisal","year":"2019","journal-title":"Patient Saf Surg"},{"key":"R24-36-20240830","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.breast.2020.08.007","article-title":"Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis","volume":"53","author":"Wijaya","year":"2020","journal-title":"Breast"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_281_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:32:08Z","timestamp":1787772728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_281_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_281_21","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}